Droperidol (American Regent, Inc.)


Welcome to the PulseAid listing for the Droperidol drug offered from American Regent, Inc.. This Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: Droperidol
SUBSTANCE NAME: DROPERIDOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00


Droperidol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDroperidol from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(mg/mL)
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-9702_b135de7c-8def-431a-a5cc-1c1d98cc6161
PRODUCT NDC: 0517-9702
APPLICATION NUMBER: ANDA072123

Other DROPERIDOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Droperidol
Cardinal HealthDroperidol
Hospira, Inc.Droperidol